Extended-spectrum β-lactamase and carbapenemase production among burn and non-burn clinical isolates of Klebsiella pneumoniae
,
Abstract
Background and Objectives: Klebsiella pneumoniae is an opportunistic pathogen responsible for up to 10% of nosocomial infections. The emergence and spread of multidrug resistant K. pneumoniae, mostly due to the production of extended-spec- trum β-lactamases (ESBL) and carbapenemases, is often responsible for antibiotic treatment failure of these infections. We compared the antibiotic resistance profiles, ESBL and carbapenemase production as well as presence of KPC-type genes in burn and non-burn clinical isolates of K. pneumoniae.
Materials and Methods: Fifty five clinical isolates were collected from Shahid Motahari (25 burn isolates) and Shariati (30 non-burn isolates) hospitals between August 2011 to January 2012. Antibiotic susceptibility was determined to 12 antibiot- ics using disc diffusion. The phenotypic confirmatory test (PCT) was used to screen for ESBL production. Carbapenemase activity was measured by the modified Hodge test (MHT) and KPC-type carbapenemases were further sought by PCR using specific primers.
Results: Both groups were highly resistant to cefotaxime and ceftazidime (>92%). Burn isolates were significantly more resistant to cefepime, amoxiclav, imipenem, meropenem, gentamicin and ciprofloxacin compared to the non-burn strains (p<0.05). No significant differences were observed in ESBL production between the two groups. Carbapenem resistance was only observed among the burn isolates (n=5, 9.1%). Five carbapenem-resistant isolates produced carbapenemases. However, none of the isolates harbored the KPC-type genes.
Conclusion: Higher rates of drug resistance were observed in burn isolates of K. pneumoniae compared to the non-burn strains. Carbapenemase phenotype was only observed among the burn isolates but KPC-type gene was not detected.
Podschun R, Ullmann U. Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods and pathogenicity factors. Clin Microbiol Rev 1998;11: 589-603.
Paterson DL, Bonomo RA. Extended-spectrum β-lact- amases: a clinical update. Clin Microbiol Rev 2005; 18:657–686.
Bradford PA. Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin microbiol Rev 2001; 14: 933-951.
Patel JB, Rasheed JK, Kitchel B. Carbapenemases in Enterobacteriaceae: activity, epidemiology, and labo- ratory detection. Clin Moicrobiol News 2009; 31: 55-62.
Papp-Wallace KM, Endimiani A, Taracila MA,Bonomo RA. Carbapenems: past, present, and future.Antimicrob Agent Chemother 2011; 55: 4943-4960.
Coque T, Baquero F, Canton R. Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe. Eurosurveillance 2008; 13: 19-29.
Queenan AM, Bush K. Carbapenemases: the versatile β-lactamases. Clin Microbiol Rev 2007; 20:440-458.
Walsh TR. Emerging carbapenemases: a global per- spective. Int J Antimocrob Agent 2010; 36:S8-S14.
Yigit H, Queenan AM, Anderson GI, Domenech-Sab- chez A, Biddle JW, Stewart CD, et al. Novel carbap- enem-hydrolizing β-lactamase, KPC-1 from a car- bapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agent Chemother 2001; 45: 1151-1161.
Bradford PA, Bratu S, Urban C, Visalli M, Mariano N, Landman D, et al. Emergence of carbapenem-re- sistant Klebsiella species possessing the class A car- bapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 β-lactamases in New York City. Clin Infect Dis 2004; 39: 55-60.
Tzouvelekis S, Markogiannakis A, Psichogiou M, Tassios PT, Daikos GL. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolv- ing crisis of global dimensions. Clin Microbiol Rev 2012; 25: 682-707.
Villegas MV, Lolans K, Correa A, Suarez CJ, Lopez JA, Vallejo M, et al. Colombian Nosocomial Resistance Study Group. First detection of the plasmid-mediated class A carbapenemase KPC-2 in clinical isolates of Klebsiella pneumoniae from South America. Antimicrob Agent Chemother 2006; 50: 2880-2882.
Naas T, Nordmann P, Vedel G, Poyart C. Plasmid-me- diated carbapenem-hydrolizing β-lactamase KPC iso- lates from France. Antimicrob Agent Chemother 2005;49:4423-4424.
Clinical and Laboratory Standards Institute. Perfor- mance Standards for Antimicrobial Susceptibility Testing; 21st Informational Supplement M100-S21. CLSI. Wayne, PA. USA 2011.
Clinicaland Laboratory Standards Institute. Perfor- mance Standards for Antimicrobial Susceptibility Testing: 19th Informational Supplement M100-S19. CLSI document Wayne, PA. USA 2009.
Clinical and Laboratory Standards Institute. Per- formance Standards for antimicrobial susceptibility testing; M100-S21. CLSI document Wayne, PA. USA 2011.
Cheng HR, Jiang N. Extremely rapid extraction of DNA from bacteria and yeasts. Biotechnol Lett 2006;28: 55-59.
Park YS, Lee H, Lee KS, Hwang SS, Cho YK, Kim HY et al. Extensively drug-resistant Acinetobacter baumannii: risk factors for acquisition and prevalent OXA-type carbapenemases: a multi-centre study. Int J ntimicrob Agents 2010; 36: 430-435.)
Feizabadi MM, Mahamadi-Yeganeh S, Mirsalehian A, Mirafshar SM, Mahboobi M, Nili F, et al. Genetic characterization of ESBL producing strains of Klebsi- ella pneumoniae from Tehran hospitals. J Infect Dev Ctris 2010; 4: 609-615.
Ghafourian S, Sekawi Z, Neela V, Khosravi A, Rahbar M, Sadeghifard N. Incidence of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in patients with urinary tract infection. Sao Paulo Med J 2012; 130: 37-43.
Mehrgan H, Rahbar M, Arab-Halvaii Z. High preva- lence of extended-spectrum beta-lactamase producing Klebsiella pneumoniae in a tertiary care hospital in Tehran, Iran. J Infect Dev Ctries 2009; 4(03): 132-138.
Anderson KF, Lonsway DR, Rasheed JK, Biddle J, Jensen B, McDougal K, et al. Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae. J Clin Microbiol 2007; 45: 2723-2725.
Yagi T, Wachino JI, Kurokawa H, Suzuki S, Yamane K, Doi Y, et al. Practical methods using boronic acid compounds for identification of class C β-lactamase producing Klebsiella pneumoniae and Escherichia coli. J Clin Microbiol 2005; 43: 2551–2558.
Munoz-Price, LS. Quinn JP. The Spread of Klebsiella pneumoniae carbapenemases: a tale of strains, plasmids and transposons. Clin Infect Dis 2009;49:1739-1741.
Haji Hashemi B, Farzanehkhah M, Dolatyar A, Imani M, Farzami MR, Rahbar M, et al. A study on preva- lence of KPC producing from Klebsiella pneumoniae using Modified Hodge Test and CHROMagar in Iran. Ann Biolog Res 2012; 3 :5659-5664.
Azimi L, Rastegar Lari A, Alaghehbandan R, Aline- jad F, Mohammadpoor M, Rahbar M. KPC-produc- er gram negative bacteria among burned infants in Motahari Hospital, Tehran: first report from Iran. Ann Burns Fire Disasters 2012; 25: 74–77.
Kalantar-Neyestanaki D, Fatahi Bafghi M. The Mod- ified Hodge Test: Is it an appropriate method for de- tection of KPC enzyme or not? Iran J Microbiol 2015;7:123-124.
| Files | ||
| Issue | Vol 7 No 3 (2015) | |
| Section | Articles | |
| Keywords | ||
| Klebsiella pneumoniae ESBL extended-spectrum β-lactamase carbapenemase KPC | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
